Platelet scintigraphy (PSC) with indium-Ill labelled platelets has been confirmed as an adequate method for the detection of intracardiac thrombi in patients with heart disease. We performed PSC of the heart and the neck vessels in 27 stroke patients with suspected cardiac embolism and as control on 10 patients with atherosclerotic lesions of the carotid arteries without evidence of heart disease. The carotid PSC was positive in 6 of 10 patients with carotid disease, and twice in the 27 with suspected cardiac embolism. In these 27 the PSC of the heart indicated pathological conditions 13 times. Pathological platelet accumulations could be visualized in 3 cases in the atrial space, in 9 cases in the region of the left ventricle, and once at the aortic valve. Scintigraphy was negative in all 10 patients with atherosclerosis of the neck vessels. The two-dimensional ecbocardiography revealed pathological findings in 8 of the 13 patients with positive heart PSC (3 with intraventricular thrombi, 3 with valvular disease, 2 with decreased ventricular contractility) and was normal in the 10 control patients. Open-heart surgery was performed in 2 patients with pathological PSC and revealed an intracardiac thrombus. Three of 4 patients with positive atrial PSC showed mitral or aortic valve disease. These results suggest that PSC can provide a valuable method for detecting cardiac thrombi in stroke patients. (Stroke 1987;18:63-#7) C ARDIAC embolism (CE) is a frequent cause of stroke. As recent studies show, the incidence of CE in stroke patients is estimated at between 15 and 35%.
C ARDIAC embolism (CE) is a frequent cause of stroke. As recent studies show, the incidence of CE in stroke patients is estimated at between 15 and 35%. 1 2 Autopsy series of stroke patients demonstrated that the incidence of possible embolism of cardiac origin is even higher. 3 In most cases the diagnosis of CE can be established only by using clinical criteria-for example, the presence of atrial fibrillation, valvular disease, cardiomyopathy, or rheumatic heart disease. 45 Some improvement in the diagnosis of CE was achieved by two-dimensional echocardiography (2 d-E), which renders possible the visualization of intracardial masses as well as the verification of other heart diseases, e.g., valvular disease, ventricular aneurysms, and immobile segments of the ventricular wall. After myocardial infarction (MI) 2 d-E can visualize an intraventricular thrombus in about 15% of the patients. 67 identification of atrial thrombi is very rare, literature on the subject being very sparse. In most instances 2 d-E fails to identify intracardial thrombi in stroke patients, the diagnosis of CE thus being mostly determined clinically. Both heart disease and atherosclerosis of the vessels supplying the brain are possible sources of embolism and coexist in many cases. Efforts of recent research have therefore aimed at creating a technique that would allow identification of the source of embolism directly. The scintigraphic technique with [In]oxine-labelled platelets has proven to be a useful in vivo method for thrombus detection.
Platelet scintigraphy (PSC) has been used for diagnosing deep vein thrombosis, 10 pulmonary embolism," and atherosclerotic lesions of the neck vessels.
12 " 14 Riba et al 15 were the first to show this new method to be very sensitive in visualizing experimentally induced intracardial thrombi in animals. Other clinical studies demonstrated the high sensitivity and specificity of PSC in the evaluation of cardiac thrombi in patients with heart disease. 1617 The value of PSC in stroke patients with the clinical diagnosis of CE has so far not been evaluated in the literature. We performed PSC of the heart and the neck vessels in 27 patients with suspected CE as well as on a control group of 10 patients with atherosclerosis of the neck vessels without evidence of cardiac disease.
Subjects and Methods
PATIENTS WTTH CARDIAC EMBOLISM. The clinical data for the 27 patients with suspected CE are listed in Table 1 ; 22 patients were men, 5 women; the mean age was 55.6 years. Sixteen patients had a stroke, 11 transient ischemic deficits. None of the patients showed any evidence of inflammatory vessel disease. Eight patients had an MI before cerebral ischemia, 10 atrial fibrillation, 6 heart enlargement, 7 coronary heart disease, and 3 rheumatic heart disease. CONTROL GROUP. Ten stroke patients with atherosclerosis of the carotid arteries and carotid symptoms served as control group (8 men, 2 women). None of these patients had any heart disease in their medical history; cardiac investigations, which included 2 d-E, were normal. Four patients had ulcerated carotid stenoses of about 50%, 4 high-grade stenoses, and 2 occlusions of the symptomatic carotid artery.
All scintigrams were performed within 10 days of the stroke.
Labelling Procedure
The platelets were labelled according to a modification' 8 of the method described by Thakur et al: 19 60 ml of venous blood was anticoagulated with an acid citrate dextrose (ACD formula A) solution (1:8) . A compact platelet pellet was obtained by two differential centrifugation steps (120g for 15 minutes, l,200g for 7 minutes), washed once in an ACD A/normal saline buffer solution at pH 6.5, and incubated for 20 minutes at room temperature with 500-750 /xCi of a commercially available ['"In]oxine solution. The labelled platelets were washed a second time with the buffer solution and injected intravenously after resuspension in patient's plasma. The labelling efficiency was in the range of 55-92%.
Image Processing
Scintigraphic images were obtained with a conventional gamma camera using a medium-energy parallelhole collimator. The images of the heart were obtained in the anterior-posterior and the 45° left anterior projection 24, 48, and 72 hours after injection of the labelled platelets. Additionally, the neck vessels of each patient were scanned 1 and 24 hours after injection of the radiolabelled platelets in an anterior-posterior projection. MCA occlus.
24
TIA, transient ischeraic attack; CS, completed stroke; MI, myocardial infarction; Interv., interval stroke-MI (days); HE, heart enlargement; CHD, coronary heart diseaje; RHD, rheumatic heart disease.
ICA, internal carotid artery ; MCA, median cerebral artery; PCA, posterior cerebral artery; BE, basilar embolism; MVD, mitral valvular disease; AVD, aortic valvular disease; DVC, decreased ventricular contractility; AT, atrial thrombus; LVT, left ventricular thrombus; AVT, aortic valvular thrombus.
Results

Carotid PSC
The carotid PSC was positive in 6 of the 10 control patients with carotid disease; 4 patients were shown to have ulcerated stenoses and 2 severe carotid stenoses. PSC was negative in the 2 patients with thrombotic carotid occlusion. Of the 27 patients with suggested CE, carotid PSC showed only 2 abnormal scans. One patient (No. 14) showed 50% stenosis of the right carotid artery. He had an MI one day prior to a rightsided hemispheric stroke. In this case PSC was positive in the right carotid bifurcation but negative in the heart. The other patient (No. 1) with a severe rightsided hemiparesis had atrial fibrillation as well as cardiomyopathy due to chronic alcoholism. Angiography revealed the occlusion of the left internal carotid artery, and PSC showed a thrombus formation in the atrial space as well as in the left carotid artery, representing the occluding embolic material.
Cardiac PSC
Cardiac PSC was normal in all 10 control patients with atherosclerosis of the carotid arteries. In the 27 stroke patients with a clinical diagnosis of CE, PSC revealed 13 pathological cardiac platelet accumulations: 3 in the atrial space (Figure 1 ), 9 left ventricular thrombi (LVT; Figure 2 ), and 1 aortic valve thrombus (AVT). Table 2 shows a synopsis of the additional cardiac diseases and the 2 d-E in the 27 stroke patients. Of the 3 patients with positive PSC in the atrial space 2 had a mitral valvular disease diagnosed by 2 d-E, 3 a heart enlargement, and 2 an atrial fibrillation. In the 9 patients with a left ventricular thrombus diagnosed by PSC, 2 d-E twice revealed a decreased ventricular contractility, 5 experienced an MI prior to the stroke, 6 had coronary heart disease, 3 heart enlargement, and 2 rheumatic heart disease. The patient with an aortic valvular thrombus had heart enlargement and aortic valvular disease in 2 d-E examination. Of the 14 patients with negative PSC, 3 had rheumatic disease and only 1 coronary heart disease.
In summary: Our patients with positive and negative PSC differed concerning the incidence of coronary heart disease and pathological 2 d-E findings. There was no difference concerning the incidence of MI, heart enlargement, atrial fibrillation, or rheumatic heart disease.
The angiographical findings are listed in Table 1 ; 19 patients showed a normal angiogram on the symptomatic side, 1 patient had a stenosis of the internal carotid artery (ICA), and 7 patients typical angiographic findings suggesting an embolic event (3 ICA occlusions and recanalization within 4 weeks, 1 basilar embolism, 2 occlusions of the median cerebral artery, and 1 occlusion of the posterior cerebral artery without evidence for atherosclerosis).
Discussion
In a recent issue of this journal, Caplan et al 1 complained that "defining and diagnosing cerebral embolism has proven as difficult as capturing an attractive but elusive butterfly." In their study they categorized 45 of 127 patients (34.4%) with clinical evidence for cerebral embolism under the label of "uncertain source of embolism," using clinical criteria and echocardiographic examination. Most other investigators found an equally low yield of echocardiographic results in stroke patients. 820 This fact limits prospective studies concerning a rational therapy for patients with CE. Especially in patients without history of heart disease, the routine use of 2 d-E among the diagnostic tools seems unsatisfactory. Additionally, clinical criteria for diagnosing embolic stroke as the presence of atrial fibrillation, the sudden onset of the stroke, valvular • V? * •* To date there is no report about the diagnostic value of cardiac platelet scanning in stroke patients with a possible cardiac source of embolism. We found pathological intracardiac platelet accumulations in 13 of 27 patients with the clinical diagnosis of CE, but none in control patients with atherosclerotic neck vessels. Thus, we obtained neither a false-positive nor a false-negative result, PSC having detected all three 2 d-E LVT findings. Additionally, in 10 other cases PSC showed a cardiac thrombus undetected by 2 d-E. These patients showed either other 2 d-E abnormalities or typical angiographical changes suggesting CE.
The high percent of positive cardiac scans is a result of the selection of the patients. In the CE group we only examined patients with heart disease who were known to bear a high risk of CE. In 3 patients 2 d-E was positive but PSC negative. We agree with Stratton and his coworkers 16 that PSC and 2 d-E are not competitive but complementary methods. PSC was able to identify atrial thrombi in 3 patients. A negative PSC does not mean that there is no thrombus, but it suggests that the thrombus is not yet active and not able to incorporate circulating platelets. Although all examinations were performed within 10 days of the stroke, it is possible that the thrombus was already organized. On the other hand, the time between MI and stroke differed highly (Table 1) , as in one case we obtained a positive cardiac PSC even one year after MI, whereas in another case (No. 5) a positive PSC was recorded immediately after a stroke.
In 2 patients with the clinical diagnosis of CE we obtained pathological carotid scintigrams. In one patient we found a pathological scan of the heart as well as one occluded carotid artery, indicating that the occluding embolism continued to pick up radiolabelled platelets. The other patient with a pathological carotid PSC experienced a stroke one day prior to MI. In this patient the cardiac scan was negative, but there was a platelet accumulation in the area of a 50% carotid stenosis. This case shows that the simultaneous scanning of heart and neck vessels might be of benefit in identifying the source of embolism. In diagnosing carotid thrombi, PSC has revealed itself to be a reliable noninvasive method. 1318 In concordance with these reports, our control group confirms a 60% positive PSC rate for the symptomatic side.
The results of this preliminary study suggest that PSC is an important tool in the attempt to identify the source of embolism in stroke patients, but further investigation with more patients is necessary.
